institutionsInstitution
Fondazione IRCCS Istituto Nazionale dei Tumori
The Istituto Nazionale dei Tumori is Italy's national cancer institute and a leader in sarcoma, thoracic oncology, and immunotherapy.
Sarcoma reference centre, HIPEC/peritoneal surgery, early-phase trials.
Location
Milan, IT
Type
cancer center
Website
Newsweek 2026 oncology rank
#27
OnCo score
#50 · 43 points (33 Newsweek + 0 NCI + 10 from 5 linked objects) · ranking
- Sarcoma
- Peritoneal surface malignancy
Alessandro Gronchi
Chair, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori
Sarcoma surgeryRetroperitoneal sarcomaNeoadjuvant chemotherapy
Sarcoma surgeon who led the ISG-STS 1001 trial of histology-tailored neoadjuvant chemotherapy.
Filippo de Braud
Director, Medical Oncology and Hematology, INT Milan; Professor, University of Milan
Medical oncologyEarly-phase trialsGastrointestinal cancers
Filippo de Braud heads medical oncology and the phase 1 programme at Italy's national cancer institute.
Marco Guzzo
Head, Head and Neck Surgery, INT Milan
Head and neck surgerySalivary gland tumours
Marco Guzzo is a head and neck surgeon at INT Milan.